Man holding a jar of KINSYN Exosome face creamKINSYN Exosome cream on a basin counter in morning light
UAE & GCC market entry · August 2026

KINSYN x Think8

A market-entry dossier prepared by think8 for KINSYN — regulatory pathway, live shelf pricing and an eight-month plan to launch.

The finding
01 / 02
Opportunity · the finding

Register nine. Market five. Lead with the cream.

We assessed every SKU in the KINSYN catalogue against UAE regulatory pathway, live shelf pricing and channel fit. Nine can be imported and sold. Eight cannot — and the eight are the ones the current business model is built on. That is the finding, and it is why this document exists.

01

Register nine

Registration cost is largely fixed per entity. Filing all nine at once means the regional page opens with a shelf, not a shortlist — and every later SKU is already cleared.

02

Market five

Five SKUs carry the campaign. They were selected on regulatory grounds, and the margin analysis independently selected the same five.

03

Lead with the cream

The hero product is the halo — it carries the event, the ambassador and the PR. The supplements convert that attention into recurring revenue.

Scope · exclusions

What cannot come

Delivered first, deliberately. Every one of these is a wall we found before a dirham was committed to walking into it. The prescription and compounded lines are carved out of scope in writing — that protects KINSYN as much as it protects us.

Women's health line

Vaginal HA suppository · Triphasic vaginal probiotic · HRT

Compounded, patient-specific preparations are not a registrable product class in the UAE. The only lawful route is a UAE-licensed clinic or compounding pharmacy formulating locally under prescription — which Dubai clinics already do.

No import pathway

Compounded GLP-1s

Semaglutide · Tirzepatide

Unregistered copies of registered prescription medicines. Supplying prescription medicines without authorisation carries fines, licence suspension and legal action in the UAE. This is the reputational tail risk on the whole engagement and is scoped out in writing.

Not registrable

Injectables

NAD+ · Glutathione

Must be administered in a licensed facility by licensed staff. Widely offered in Dubai longevity clinics today — but as a service, not a shipped product. A clinic partnership can deliver these; a distribution entity cannot.

Clinic service only

RMH Peptide

Peptide for fat metabolism

Peptides marketed for fat metabolism are not generally accepted as food supplements in the UAE. If MOHAP classifies it as a drug it needs a full pharmaceutical dossier and becomes prescription-only. The single most uncertain SKU in the catalogue — worth an early ruling.

Likely pharmaceutical

The telehealth model

Consultation · labs · prescribing · recurring shipment

Requires a DHA-licensed facility with telehealth authorisation, UAE-resident data hosting under Federal Law No. 2 of 2019, NABIDH integration, UAE-licensed prescribers and a separately licensed tele-dispensing pharmacy. A healthcare licensing programme on its own clock — not a market entry.

Separate programme
Research

The market we are entering

A volume category, not a luxury one. Large, growing fast, and already crowded with established US and European brands holding shelf. KINSYN has no pricing premium here and no incumbent position — differentiation has to come from the principal, the clinical framing and the bundle.

$570–620M
UAE dietary supplements market

Growing 11%+ a year. Use this as the addressable denominator, not the $2.19B nutraceuticals figure.

Grand View Research · Precedence Research
~35%
Online share of UAE nutraceuticals

And expanding. Supplement e-commerce alone is running at AED 1.5B.

Precedence Research · Research and Markets
2,489
SKUs already listed on Hewyn

200+ brands, shipping to six GCC markets from one listing. Stocks Thorne, Seed, Momentous, Pure Encapsulations.

hewyn.com, July 2026
55%
of UAE consumers buy supplements

For immunity and general health. MOHAP has reported a 20% rise in vitamin and mineral sales.

Research and Markets
Channels

Where it sells

One structural change from the deck: for this portfolio, clinics move to Phase 1. The deck sequenced them third because it was built around the cream. A practitioner-recommended supplement stack sidesteps the retail shelf fight entirely and reuses the credibility engine we already sell.

Hewyn

Premium wellness e-tail
AED 60–530
Primary

The exact price band this portfolio occupies, with taxonomies already built for NAD+, collagen, creatine, colostrum and gut health. One listing reaches six GCC markets.

BHealth

Practitioner-grade shop
AED 60–460
Primary

Clinician-trusted framing matches KINSYN's positioning better than any mass channel. Smaller than Hewyn, higher credibility density, and the natural bridge into clinics.

Longevity & aesthetic clinics

Practitioner dispensing
At or above RRP
Primary

The best strategic fit in the portfolio and the one that most reuses think8's existing access. Doctor recommendation does the work a luxury shelf did for the cream. Phase 1 for this range, not Phase 3.

Life Pharmacy · Aster · BinSina

National pharmacy chains
AED 40–400
Secondary

Slower listing cycles and tighter margin, but pharmacy shelf presence is what makes a health brand credible to a Gulf consumer.

Noon · Amazon.ae

Marketplaces
AED 30+
Secondary

Necessary for discovery and search capture. Expect margin compression and grey-import competition from cross-border sellers on the same SKUs.

Gyms, padel, hotel wellness

Performance retail
AED 80–400
Opportunistic

Creatine and Colostrum fit; nothing else does. Worth a pilot rather than a channel investment.

Hero product

KinSyn Exosome

The halo SKU. A topical cosmetic, not a supplement — a different registration pathway, a different shelf, and the only product in the range that can carry an event, an ambassador and a PR programme on its own.

KINSYN Exosome cream

Visible firmness and renewal for the neck and jawline.

KinSyn Exosome is a topical cream powered by plant-derived exosome technology, formulated to improve the look of firmness, texture and crepiness where skin ages fastest.

One-time
AED 1,200
Subscribe
AED 1,100
Benchmark
AED 1,250
Max ex-works
AED 478

Cosmetic pathway — Dubai Municipality cosmetic product notification (Montaji), not a supplement dossier. Ingredient list screened against the GSO restricted list, bilingual label, GMP and free-sale evidence.

Open the Exosome product page
Portfolio · launch five

The five that carry the campaign

Selected on regulatory grounds first. Every price, ceiling and margin below recalculates live from the pricing model — move the assumptions and watch the portfolio move with them.

01 · Longevity

NAD Support Daily

Clears
KINSYN NAD Support Daily
60 capsules · 2/day · 30 servings
NAD3 · BioPQQ · Quercefit · TMG

Highest value SKU in the portfolio and the one with a proven UAE shelf. Hewyn already runs a dedicated NAD+ Longevity category, and Tru Niagen built that shelf on published trials alone — no celebrity, no event. A deliberate undercut of the category anchor buys share without discounting the brand.

What to watch

Different actives to Tru Niagen, so this is a price-position call rather than a like-for-like claim. Branded actives also carry real licence cost — the margin here is the one most sensitive to KINSYN's true COGS.

HewynLongevity clinicsBHealthPharmacy
View the proposed product page
Proposed UAE shelfAED 385
Benchmark · Tru NiagenAED 481
Nicotinamide riboside 300mg
Position20% under benchmark
Ceiling ex-worksAED 153
KINSYN margin at ceiling38%
US list priceAED 290
Regulatory

Tier 1 — clear. Dubai Municipality via Montaji. Bilingual label, COA from an ISO-accredited lab, stability data, free sale certificate, GMP evidence.

02 · Immune & recovery

Colostrum

Clears
KINSYN Colostrum
120g powder · 4g serve · 30 servings
Bovine colostrum

The clearest unit argument in the portfolio. A 4g serve against Cowboy's 2g means AED 2.38 per gram versus their 4.14 — a 43% value advantage that the headline price hides. Category velocity in the Gulf is real and rising.

What to watch

Sits above the benchmark on shelf price. The page has to lead with grams, not dirhams, or it reads as expensive. Bovine origin means halal certification will likely be requested at registration.

HewynBHealthNoonAmazon.aeGyms
View the proposed product page
Proposed UAE shelfAED 285
Benchmark · Cowboy ColostrumAED 248
Bovine colostrum, 2g serve
Position15% over benchmark
Ceiling ex-worksAED 114
KINSYN margin at ceiling32%
US list priceAED 239
Regulatory

Tier 1 — clear. Halal certification likely requested given bovine origin. Build the lead time in.

03 · Beauty & structural

Collagen

Clears
KINSYN Collagen
300g powder · 10g serve · 30 servings
Grass-fed collagen peptides · Yuth spermidine · Vitamin C

The bridge SKU. It is the only product in the range that also reaches the beauty channels the hero cream will live in, which means one listing conversation opens two doors. Spermidine and Vitamin C put it above a commodity peptide.

What to watch

Positioning-dependent, and the most fragile argument in the set. Benchmarked against the value end of the shelf it does not clear margin. It only works priced into the mid-band, where Hewyn's collagen listings run AED 227–453. If anyone anchors it to Sports Research, the case collapses.

HewynBHealthGold AppleFacesClinics
View the proposed product page
Proposed UAE shelfAED 199
Benchmark · Sports ResearchAED 124
Collagen peptides Type I & III
Position60% over benchmark
Ceiling ex-worksAED 79
KINSYN margin at ceiling41%
US list priceAED 143
Regulatory

Tier 1 — clear. Bovine origin; halal certification may be requested.

04 · Foundational

Women's Daily Multivitamin

Clears
KINSYN Women's Daily Multivitamin
120 capsules · 4/day · 30 servings
Methylated vitamins · phytonutrients

Carries the women's health narrative with none of the regulatory exposure that the prescription line brings. Priced at parity with Thorne — the practitioner-grade benchmark — and methylated formulation supports the position rather than undercutting it.

What to watch

A crowded foundational category. This SKU wins on brand and practitioner recommendation, not on product differentiation.

HewynBHealthLife PharmacyNoon
View the proposed product page
Proposed UAE shelfAED 172
Benchmark · ThorneAED 172
Basic Nutrients 2/Day
PositionAt benchmark
Ceiling ex-worksAED 68
KINSYN margin at ceiling32%
US list priceAED 143
Regulatory

Tier 1 — clear. Straightforward supplement dossier.

05 · Performance

Creatine

Clears
KINSYN Creatine
162g powder · 5g creatine · 30 servings
Creatine monohydrate

Sports nutrition is the fastest-growing supplement segment in the UAE. This is the SKU that opens the gym, padel and hotel-wellness circuit — channels none of the others reach — at a price the category already accepts.

What to watch

Thorne carries NSF certification, which matters to serious buyers. Parity is the ceiling here, not a discount position. Commodity category with heavy grey-import competition.

HewynNoonAmazon.aeGym retailPadel clubs
View the proposed product page
Proposed UAE shelfAED 129
Benchmark · ThorneAED 129
Micronized creatine, NSF certified
PositionAt benchmark
Ceiling ex-worksAED 51
KINSYN margin at ceiling33%
US list priceAED 107
Regulatory

Tier 1 — clear. Lowest-friction registration in the range.

Portfolio · held back

Sequenced behind

Registered alongside the launch five so the shelf has depth from day one, but held out of the campaign. Berberine is first in the queue — it clears better margin than three of the launch five and is gated only on claim language.

06 · Metabolic

Berberine Complex

Clears
KINSYN Berberine Complex
60 capsules · 2/day · 30 servings
Berbevis® enhanced-absorption berberine

Commercially the strongest of the four held back — it clears better margin than three of the launch five. It is gated on claim language, not economics. First in the queue once MOHAP rules.

What to watch

Glycaemic positioning sits close to a therapeutic claim. UAE rules prohibit any cure, treatment or prevention claim on label, brochure or advertising. Expect a claim rewrite or a push onto the pharmaceutical pathway.

HewynBHealthClinics
View the proposed product page
Proposed UAE shelfAED 200
Benchmark · ThorneAED 210
Berberine 500–600mg
Position5% under benchmark
Ceiling ex-worksAED 79
KINSYN margin at ceiling34%
US list priceAED 162
Regulatory

Tier 2 — claim risk. Requires a MOHAP classification opinion before registration budget is committed.

07 · Gut health

Prebiotic Fiber

Tight
KINSYN Prebiotic Fiber
198g powder · 6.6g serve · 30 servings
Pre / pro / postbiotic blend

Registered but not marketed at launch. Format and serve are near-identical to the benchmark, which leaves little room to argue a premium.

What to watch

Runs tight on margin at any defensible shelf price. Add it to the range once the brand carries a price premium of its own.

HewynBHealthKibsonsNoon
View the proposed product page
Proposed UAE shelfAED 167
Benchmark · Physician's ChoiceAED 152
Prebiotic fiber, 6.7g serve
Position10% over benchmark
Ceiling ex-worksAED 67
KINSYN margin at ceiling21%
US list priceAED 162
Regulatory

Tier 1 — clear. Register alongside the launch five.

08 · Metabolic

Metabolic Daily

Tight
KINSYN Metabolic Daily
60 capsules · 2/day · 30 servings
Gut and metabolic blend

At parity on a like-for-like 30-day supply with no structural pricing advantage, and carrying the same claim exposure as Berberine.

What to watch

'Appetite regulation' is the specific wording at risk. Runs tight on margin even before the claim question is settled.

HewynBHealthClinics
View the proposed product page
Proposed UAE shelfAED 167
Benchmark · JSHealthAED 167
Metabolism & Sugar Support
PositionAt benchmark
Ceiling ex-worksAED 66
KINSYN margin at ceiling21%
US list priceAED 162
Regulatory

Tier 2 — claim risk. MOHAP classification opinion required.

09 · Women's health

PCOS Support

Below floor
KINSYN PCOS Support
120 capsules · 4/day · 30 servings
Myo-inositol 40:1 · Chromax · NAC · spearmint · GlucoVantage

Held back for two independent reasons, which is why it sits last. The formulation is genuinely richer than the benchmark, but the shelf it competes on is cheap.

What to watch

Fails the margin floor before the naming problem is even reached. A UAE supplement label may not name a diagnosed medical condition — a rename such as 'Cycle & Hormone Support' is the likely condition of approval.

Gynae clinicsWomen's health clinicsBHealth
View the proposed product page
Proposed UAE shelfAED 173
Benchmark · Wholesome StoryAED 144
Myo-Inositol & D-Chiro 40:1
Position20% over benchmark
Ceiling ex-worksAED 69
KINSYN margin at ceiling15%
US list priceAED 180
Regulatory

Tier 2 — condition-named. Rename almost certainly required. MOHAP ruling needed.

Pricing model

One number we don't have

Competitor shelf prices are live from Hewyn. KINSYN's US prices are published. Duty, VAT and the dirham peg are fixed. Channel margins are published industry bands. There is exactly one input in this model we cannot source — KINSYN's cost of goods — and it is the only one flagged amber. Move it and watch what happens.

Live pricing model
2.51×

Every dirham of ex-works price becomes AED 2.51 on a UAE shelf once freight, 5% duty, distributor margin, retailer margin and 5% VAT are applied. This is why a UAE price sits above a US direct-to-consumer price: one margin becomes three.

5 of 5 launch SKUs clear the 25% margin floor at these settings.

68%
50%85%ASSUMED
35%
20%50%STANDARD
28%
15%40%STANDARD
12%
5%25%STANDARD
VAT fixed 5%Margin floor 25%
Proposed shelf price against the live UAE benchmark · AED
01 · Longevity

NAD Support Daily

Clears
Tru Niagen481
KINSYN385
AED 0AED 615
02 · Immune & recovery

Colostrum

Clears
Cowboy Colostrum248
KINSYN285
AED 0AED 365
03 · Beauty & structural

Collagen

Clears
Sports Research124
KINSYN199
AED 0AED 255
04 · Foundational

Women's Daily Multivitamin

Clears
Thorne172
KINSYN172
AED 0AED 220
05 · Performance

Creatine

Clears
Thorne129
KINSYN129
AED 0AED 165
06 · Metabolic · Held

Berberine Complex

Clears
Thorne210
KINSYN200
AED 0AED 269
07 · Gut health · Held

Prebiotic Fiber

Tight
Physician's Choice152
KINSYN167
AED 0AED 214
08 · Metabolic · Held

Metabolic Daily

Tight
JSHealth167
KINSYN167
AED 0AED 214
09 · Women's health · Held

PCOS Support

Below floor
Wholesome Story144
KINSYN173
AED 0AED 221
Execution

Ten months to launch

Each month produces a deliverable and closes a gate. The retainer is paid against the gate, not the calendar — which makes it accountability rather than a subscription.

Month 0-1

Mobilisation

Market entry blueprint: jurisdiction recommendation (free zone vs mainland with tax and import implications), regulatory route determination (Dubai Municipality vs MOHAP), competitor and pricing landscape, and channel map. All conversations with potential partners and distributors to be set up. All decks, product formulations in our brand language, and marketing plans and activations for potential distributors and channel partners to be ready. All social media assets, regional website and potential regional brand faces identified.

Outcome

KINSYN begins with a clear, documented path to market and a resolved view of the two gates that control the clock.

Months 1–2

Entity & Gate One

Incorporate the entity, secure the correct activity codes, initiate the corporate bank account and importer-of-record structure, and assemble and submit the product registration dossier alongside a labelling compliance assessment. Socials ready to be activated, creator pipeline ready to go. UGC content bank set up.

Outcome

KINSYN is a live legal entity in the UAE with registration applications filed and reference numbers in hand.

Months 3–4

Gate Two & Channel Pre-Build

Drive the registration through query response to approval, select warehousing and 3PL (with cold-chain assessment for the exosome format), shortlist distributors and move term sheets, and open marketplace seller accounts. Create readiness for sales and purchase. Identify conferences and summits to launch, activate, exhibit at.

Outcome

Product is cleared or near-cleared for import, and a signed distributor LOI plus staged listings are in place. Sales readiness to be closer to 100%.

Months 5–6

Marketing & Clinic Build

Appoint the PR partner, build the dual-demographic ambassador roster, run outreach to 15–20 top-tier clinics with meetings booked, and lock the launch event venue and date. Already live in a few top clinics and top marketplaces.

Outcome

Signed clinic pilots, an approved regional media plan, and a confirmed launch event contract.

Month 7

Pre-Launch

Land more stock, go live with listings in all identified marketplaces and channel partners, execute influencer seeding, set the press embargo, and lock in ambassador contracts.

Outcome

A signed-off launch-readiness position — everything built, private activations, ready for the big launch event.

Month 8

Launch (Jan/Feb)

Execute the launch event and Chris fly-in, go live across retail, marketplaces and clinics, and activate the ambassador ecosystem.

Outcome

KINSYN is commercially live at peak season, with week-one and month-one sell-through reporting delivered.

Months 9-10

Post Launch

Address all inbounds, identify the next set of activations across clinics and other distribution partners, onboard more ambassadors and start speaking with neighbouring GCC countries for distributor rights and activations.

Outcome

Cash in on the launch event and PR and make sure sales reflects those activations not just in the UAE but start planning for wider GCC.

Services

What we operate

Sole appointed regional operator — not sales exclusivity. One integrated function rather than six vendors, priced against what a country manager, a regulatory consultant and a marketing lead would cost as headcount.

Regulatory

MOHAP classification opinions, Dubai Municipality registration via Montaji, dossier assembly, label compliance and Arabic artwork, halal certification where ingredient origin requires it.

Entity & trade

Jurisdiction recommendation, incorporation, activity codes, corporate banking, importer-of-record structure, customs and HS classification.

Supply chain

3PL and warehousing selection, cold-chain assessment where format requires it, landed-cost modelling, stock planning against launch phasing.

Channel & distribution

Distributor shortlisting and term negotiation, e-tail listing management, marketplace account setup, pharmacy chain introductions.

Clinic network

Access to the 15–20 top-tier longevity, aesthetic and women's health clinics already mapped. Practitioner seeding, pilot structuring, dispensing economics.

Brand & launch

PR partner appointment, regional media planning, ambassador roster and contracting, launch event production, influencer seeding.

Deck

Partnership deck

The fourteen-slide partnership case, embedded here so the whole argument sits behind one link.

Partnership deck slide 1 of 14
Partnership deck slide 2 of 14
Partnership deck slide 3 of 14
Partnership deck slide 4 of 14
Partnership deck slide 5 of 14
Partnership deck slide 6 of 14
Partnership deck slide 7 of 14
Partnership deck slide 8 of 14
Partnership deck slide 9 of 14
Partnership deck slide 10 of 14
Partnership deck slide 11 of 14
Partnership deck slide 12 of 14
Partnership deck slide 13 of 14
Partnership deck slide 14 of 14
01 / 14
DOWNLOAD PDF
Commercials

Commercials

Three layers, one timeline. The retainer buys the build and ends at launch. Pass-through costs cover the machinery, billed at cost with nothing hidden in our fee. Commission buys the run and begins at go-live.

Block 01

The two retainers

Regional Operating Partner

  • Regulatory
  • Entity Setup & Trade
  • Supply Chain Management
  • Channel & Distribution
  • Strategy
In-house equivalent ~$28–32K/mo
$20,000 / month
Monthly recurring

Marketing & Launch

  • Social Media
  • Funnel & CRM
  • Marketplace Management
  • Paid Media Management
  • Creator Partnerships
  • Events & Activations
  • Clinic Partnerships
In-house equivalent ~$22–26K/mo
$12,000 / month
Monthly recurring

Combined: $32,000/mo — against ~$50–58K to build the same team in-house. Take the operating layer alone, or both.

Block 02

The three-layer model

Layer 1

Retainer

$32K/mo × 8-month build = $256K

Fixed, gate-tied, ends at launch.

Layer 2Opened in session

Pass-throughs

At cost — 0% markup

Government & registration fees, per-SKU dossiers, lab testing, Arabic artwork, ad spend, event production, creator fees, clinic incentives. Scheduled, nothing hidden in our fee.

Layer 3

Commission

3–5% of ex-works revenue

Begins at launch. Aligns think8 to KINSYN's growth.

Build → Machinery → Run. The retainer and commission never overlap: one ends where the other begins.

Block 03

Total cost of engagement

8 months
6 – 12 months
Retainer scope
Total build-phase fee
$256,000
= $20K ops + $12K marketing, × 8 months

Pass-through costs are additional and billed at cost. See Layer 2.